Founded in 2023 by Flexpoint and CEO Dom Meffe, ArtesRx focused on building a specialized pharmacy platform for individuals managing serious mental illness and substance use disorders. Under Flexpoint’s ownership, the company implemented a dual strategy of organic growth and targeted acquisitions. This approach transformed the footprint from three pharmacies in a single state to 16 locations operating across 15 states.
Flexpoint Ford Exits Behavioral Pharmacy Platform ArtesRx
Private equity firm Flexpoint Ford has finalized the sale of ArtesRx to Linden Capital Partners, marking a rapid expansion for the pharmacy provider. Established just three years ago, the company scaled from a regional operation to a national network serving patients with complex behavioral health and developmental needs.
Management focused on professionalizing the executive leadership team and establishing a formal M&A pipeline to integrate local pharmacy banners. Michael Fazekas, managing director at Flexpoint, credited the success to the company's specific care model, which prioritizes patients requiring complex medication regimens. Houlihan Lokey acted as the financial advisor for the transaction, the terms of which remain undisclosed. ArtesRx will now continue its development under the ownership of Linden Capital Partners.
Comments (0)
No comments yet. Be the first!